Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hadoux

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 10, 2022
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and PheochromocytomasConstance Lamy, Hubert Tissot, Matthieu Faron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2018
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of <sup>18</sup>F-Fluorocholine PET/CTSerena Grimaldi, Jacques Young, Peter Kamenicky, et al.
Endocrine|October 31, 2020
Impact of expert review of histological diagnosis of papillary and follicular thyroid cancerSegolene Hescot, Hala Sheikh-Alard, Manal Kordahi, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Bulletin Du Cancer|September 6, 2013
[Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment]Julien Hadoux, Philippe Morice, Catherine Lhommé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2022
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survivalArnaud Jannin, Livia Lamartina, Coralie Moutarde, et al.
Stem Cell Research|December 4, 2017
Transcriptional landscape of a RET<sup>C634Y</sup>-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancersJulien Hadoux, Christophe Desterke, Olivier Féraud, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|August 10, 2022
Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and PheochromocytomasConstance Lamy, Hubert Tissot, Matthieu Faron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2018
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of <sup>18</sup>F-Fluorocholine PET/CTSerena Grimaldi, Jacques Young, Peter Kamenicky, et al.
Endocrine|October 31, 2020
Impact of expert review of histological diagnosis of papillary and follicular thyroid cancerSegolene Hescot, Hala Sheikh-Alard, Manal Kordahi, et al.
Neuroendocrinology|June 9, 2020
Long-Term Results after Surgical Resection of Peritoneal Metastasis from Neuroendocrine TumorsLéonor Benhaim, Matthieu Faron, Julien Hadoux, et al.
Bulletin Du Cancer|September 6, 2013
[Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment]Julien Hadoux, Philippe Morice, Catherine Lhommé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2022
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survivalArnaud Jannin, Livia Lamartina, Coralie Moutarde, et al.
Stem Cell Research|December 4, 2017
Transcriptional landscape of a RET<sup>C634Y</sup>-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancersJulien Hadoux, Christophe Desterke, Olivier Féraud, et al.
Cancers|February 25, 2022
Anaplastic Thyroid Carcinoma: An UpdateArnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2021
Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical CarcinomaAlice Boilève, Elise Mathy, Charles Roux, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Pageof 12